Ledger.Open graph →
SEC Form D · filed June 14, 2018

ADIAL PHARMACEUTICALS, INC

Offering
$325K
Sold
$325K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CHARLOTTESVILLE, VA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Ursula Newman · London, United KingdomDirectorSever Totia · New York, NYDirectorJoseph M. Truluck · Charlottesville, VAExecRobertson H. Gilliland · Charlottesville, VADirectorKevin W. Schuyler, Cfa · Charlottesville, VADirectorJesse S. Jacobs · Playa Vista, CADirectorJames W. Newman, Jr · Charlottesville, VADirectorKweli Washington · New York, NYDirectorKiran N. Bhatraju · Shepherdstown, WVDirectorMike Kerns · Playa Vista, CADirectorFred Ausubel · Allston, MAExecMatthew Tomich · New York, NYExec · DirectorThomas Scriven · Golden, CODirectorLauren Smith · Nashville, TNDirectorJames K. Anderson · Charlottesville, VADirectorJason Bergsman · Playa Vista, CADirectorPeter Feld · New York, NYDirectorCory Brown · Nashville, TNDirectorTony W. Goodman · Charlottesville, VADirectorW. C. Mccollum · Los Angeles, CAExecBankole A. Johnson · Charlottesville, VADirectorRonald Heffernan · Sandy, UTExec · DirectorMatthew Davis · Purcellville, VADirectorWilliam B. Stilley, Iii · Charlottesville, VAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗